Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis

Carcinogenesis

Volumn 31, Issue 6, 2010, Pages 1116-1123

  Pérez Lorenzo, Rolando ^a,b   Markell, Lauren Mordasky ^a   Hogan, Kelly A ^a   Yuspa, Stuart H ^c   Glick, Adam B ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSIDAD AUTÓNOMA DE CAMPECHE   (Mexico)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C ALPHA; RAS PROTEIN; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; CARCINOGEN; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EPIDERMIS CELL; GENE ACTIVATION; GENE DOSAGE; INFLAMMATION; KERATINOCYTE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA; TUMOR PROMOTION; ANIMAL; BAGG ALBINO MOUSE; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; PAPILLOMA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN TUMOR;

ANIMALS; CARCINOGENS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; MICE; MICE, INBRED BALB C; PAPILLOMA; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77953931492     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq041     Document Type: Article

References (50)

1. Glick, A.B. (2004) TGFbeta1, back to the future: revisiting its role as a transforming growth factor. Cancer Biol. Ther., 3, 276-283.
2. Cui, W. et al. (1996) TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell, 86, 531-542.
3. Weeks, B.H. et al. (2001) Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis. Cancer Res., 61, 7435-7443.
4. Mueller, M.M. (2006) Inflammation in epithelial skin tumours: old stories and new ideas. Eur. J. Cancer, 42, 735-744.
5. Akhurst, R.J. et al. (1988) Localized production of TGF-beta mRNA in tumour promoter-stimulated mouse epidermis. Nature, 331, 363-365.
6. Tang, B. et al. (1998) Transforming growth factor-β is a new form of tumor suppressor with true haploid insufficiency. Nat. Med., 4, 802-807.
7. Li, A.G. et al. (2004) Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis. Cancer Res., 64, 7836-7845.
8. Kulkarni, A.B. et al. (1992) Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl Acad. Sci. USA, 90, 770-774.
9. Liu, X. et al. (2001) Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proc. Natl Acad. Sci. USA, 98, 9139-9144.
10. Banas, M.C. et al. (2007) Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney. J. Histochem. Cytochem., 55, 275-285.
11. Li, J. et al. (2007) The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells, 25, 697-706.
12. Tait, L.R. et al. (2007) Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts. Int. J. Cancer, 120, 2127-2134.
13. Glick, A.B. et al. (1994) Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes Dev., 8, 2429-2440.
14. Nakadate, T. et al. (1988) Comparison of protein kinase C functional assays to clarify mechanisms of inhibitor action. Biochem. Pharmacol., 37, 15411545.
15. Rice, R.H. et al. (1977) The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein. Cell, 11, 417-422.
16. Rozen, S. et al. (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol., 132, 365-386.
17. Datto, M.B. et al. (1995) Transforming growth factor β induces the cyclindependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl Acad. Sci. USA, 92, 5545-5549.
18. Patamalai, B. et al. (1994) Altered expression of transforming growth factor-beta 1 mRNA and protein in mouse skin carcinogenesis. Mol. Carcinog., 9, 220-229.
19. Escherick, J.S. et al. (1993) Transforming growth factor β1 induction is associated with transforming growth factors β2 and β3 down-modulation in 12O-tetradecanoylphorbol-13-acetate-induced skin hyperplasia. Cancer Res., 53, 5517-5522.
20. Mellor, H. et al. (1998) The extended protein kinase C superfamily. Biochem. J., 332, 281-292.
21. Kim, S.J. et al. (1989) Activation of the second promoter of the transforming growth factor-beta 1 gene by transforming growth factor-beta 1 and phorbol ester occurs through the same target sequences. J. Biol. Chem., 264, 19373-19378.
22. Tsubouchi, Y. et al. (2000) Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem. Biophys. Res. Commun., 270, 400-405.
23. Hawley-Nelson, P. et al. (1982) The tumor promoter, 12-O-tetradecanoylphorbol-13-acetate accelerates keratinocyte differentiation and stimulates growth of an unidentified cell type in cultured human epidermis. Exp. Cell Res., 137, 155-167.
24. Yuspa, S.H. et al. (1982) Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res., 42, 2344-2349.
25. Ryckman, C. et al. (2003) Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol., 170, 3233-3242.
26. Tessier, P.A. et al. (1997) Chemokine networks in vivo: involvement of C-XC and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J. Immunol., 159, 3595-3602.
27. Williams, C.S. et al. (1999) The role of cyclooxygenases in inflammation, cancer, and development. Oncogene, 18, 7908-7916.
28. Balmain, A. et al. (1984) Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature, 307, 658-660.
29. Ha oncogene and its p21 product in chemically induced skin tumors and tumor-derived cell lines. Carcinogenesis, 8, 1821-1825.
30. Dlugosz, A.A. et al. (1994) Alterations in murine keratinocyte differentiation induced by activated rasHa genes are mediated by protein kinase C-alpha. Cancer Res., 54, 6413-6420.
31. Roop, D.R. et al. (1986) An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Nature, 323, 822-824.
32. Lewis, J.G. et al. (1987) Early inflammatory changes in the skin of SENCAR and C57BL/6 mice following exposure to 12-O-tetradecanoylphorbol13-acetate. Carcinogenesis, 8, 889-898.
33. Go, C. et al. (1999) Blocking transforming growth factor β signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis. Cancer Res., 59, 2861-2868.
34. Blessing, M. et al. (1995) Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-β related transgene. Teratog. Carcinog. Mutagen., 15, 11-21.
35. Breitkreutz, D. et al. (2007) Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium. J. Cancer Res. Clin. Oncol., 133, 793-808.
36. Tsunobuchi, H. et al. (2004) Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells. Biochem. Biophys. Res. Commun., 316, 712-719.
37. Runyan, C.E. et al. (2003) Smad3 and PKCdelta mediate TGF-beta1induced collagen I expression in human mesangial cells. Am. J. Physiol. Renal Physiol., 285, F413-F422.
38. Kim, Y.K. (2007) TGF-beta1 induction of p21WAF1/cip1 requires smadindependent protein kinase C signaling pathway. Arch. Pharm. Res., 30, 739-742.
39. Chow, J.Y. et al. (2008) TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol., 294, G899-G905.
40. Rutberg, S.E. et al. (1996) Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. Oncogene, 13, 167176.
41. Rutberg, S.E. et al. (1997) Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters. Oncogene, 15, 1337-1346.
42. Glick, A. et al. (2007) Context dependent regulation of cutaneous immunological responses by TGF{beta}1 and its role in skin carcinogenesis. Carcinogenesis, 29, 9-14.
43. Gebhardt, C. et al. (2002) Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene, 21, 4266-4276.
44. Ashcroft, G.S. et al. (1999) Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response [see comments]. Nat. Cell Biol., 1, 260-266.
45. Parekh, T. et al. (1994) Neutrophil chemotaxis in response to TGF-beta isoforms (TGF-beta 1, TGF-beta 2, TGF-beta 3) is mediated by fibronectin 20. J. Immunol., 152, 2456-2466.
46. Glick, A. et al. (2007) The high-risk benign tumor: evidence from the twostage skin cancer model and relevance for human cancer. Mol. Carcinog., 46, 605-610.
47. Glick, A. et al. (1999) Defects in transforming growth factor-β signaling cooperate with a ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes. Proc. Natl Acad. Sci. USA, 96, 14949-14954.
48. Darwiche, N. et al. (2007) Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion. Oncogene, 26, 6885-6895.
49. Glick, A.B. et al. (1996) Transforming growth factor-β1 suppresses genomic instability independent of a G1 arrest, p53 and Rb. Cancer Res., 56, 3645-3650.
50. Kirshner, J. et al. (2006) Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress. Cancer Res., 66, 10861-10869.